Protak Scientific Ltd. Virtual Pharma Expo May 2026: Aseptic Fill/Finish Manufacturing & Packaging
Biopharmaceutical manufacturing demands rigorous bio-decontamination protocols, yet traditional validation processes often introduce significant operational bottlenecks. Relying solely on standard biological indicators requires an incubation period of five to seven days, yielding only binary pass-or-fail results. This lack of granular data makes it difficult to pinpoint worst-case locations or optimize gassing cycles without extensive, repetitive testing cycles that drain both time and resources.
Implementing enzyme indicators as a rapid diagnostic tool transforms cycle development by delivering quantitative, real-time feedback. By measuring relative light units to establish log-reduction equivalents, these indicators provide immediate insight into gas distribution and cycle efficacy. This data-driven approach allows facilities to confidently map gas behavior, eliminate excessive overprocessing, and accelerate validation timelines while ensuring full audit readiness. Watch the video below to learn how advanced diagnostic tools can optimize your decontamination cycles and dramatically reduce validation timelines.
About Protak Scientific Ltd:
Protak Scientific provides specialist validation services for bio-decontamination processes and systems. We support pharmaceutical manufacturers, healthcare facilities, and OEM partners across the full validation lifecycle, aligning equipment design, process intent, and regulatory expectations.
Behind those services is our own technology. Protak manufactures Enzyme Indicator (EI) technology, a rapid validation tool for gaseous bio-decontamination, originally developed in collaboration with Public Health England (now the UK Health Security Agency). Pharmaceutical manufacturing is one of our largest sectors, where we supply 85% of the world's top 20 pharmaceutical companies.
We also provide validation consultancy across sectors where bio-decontamination is critical to safety and efficacy. Our ATHENA™ software delivers real-time, quantifiable results for cycle efficacy, with reporting and review features that support compliance requirements.
From designing manufacturing facilities and building bespoke equipment to managing quality assurance in pharmaceutical production, our technology gives customers a clear and effective method of bio-decontamination validation.